The European catheter market size is estimated to grow at a CAGR of 10.2% between 2021 to 2026.
The catheter market in Europe is projected to be primarily driven by the factors such as increasing focus on minimally invasive surgical procedures over conventional surgery and proliferation of chronic diseases across the European region, and growing target patient population. Also, as high blood pressure and diabetes are prone to chronic diseases, and kidney failures in intern raise the demand for the market growth. An increasing number of surgical procedures across the Europe region and prostate cancer proliferation in the developed countries such as Spain and Italy are most likely to create market growth. On the other hand, growing inclination of midscale catheter manufacturers towards attaining the largest market share. Cardiovascular disorders, urological disorders, and diabetics are the sedentary lifestyles of people in the Countries such as Germany, the UK, and Spain, indirectly increasing the catheter demand. The patients who undergo general medication need catheters, as this is expected to drive the market growth.
However, peripheral disease procedures have higher adoption rates that become standard techniques in general surgeries due to the utilization of innovative coated catheters available in the regional market. Besides, the favorable reimbursement scenario and government incentives to facilitate better healthcare facilities in the region encourage the catheter market growth. Increasing research and development activities on the catheter are expected to promote the largest share of the market. However, the growing adoption of advanced catheters in countries such as Germany, the UK, and Spain are likely to contribute to the largest share of the European regional market growth. Moreover, the government and private organizations' investment and funding to improve hospital infrastructure are expected to encourage the catheter market growth in the Europe region.
Catheterization is a painful procedure that requires inserting and removing improperly lubricated catheters, which create irritation between the urethral walls and the device's surface, which is expected to be the significant growth decline factor to the catheter market. The availability of alternative treatment procedures for urinary incontinence, on the other hand, is a substantial impediment to market growth. Catheter use has many drawbacks, including discomfort for the patient and prolonged use, narrowing of the urethra, infection, and bleeding.
Impact of COVID-19 on the European catheters market:
The sudden outbreak of COVID-19 has resulted in a nationwide lockdown, including in Europe. The catheters demand experienced a decline in growth during the first quarter of 2020 due to the sudden declaration of lockdown. Europe has announced a regional lockdown to control the covid-19 transmission. The transportation ban disrupted the catheter supply chain, resulting in a growth decline. However, after the unlock of lockdown, the European catheters market has gained momentum due to the growing demand for catheters in the region. All the resumed activities have resumed, the minimally invasive procedures have significantly increased. The growing inclination of midscale catheter manufacturers in the region is attaining the largest market share. The market is most likely to experience the largest market share in the coming years.
This research report on the European catheters market has been segmented and sub-segmented into the following categories.
By Distribution Channel:
Geographically, the catheters market witnessed significant growth in the Europe region in 2020, and it is expected to have rapid growth during the forecast period. Market growth is attributed to the rising prevalence of urinary incontinence in European countries, advancing healthcare infrastructure, increasing disposable income, and untapped opportunities in emerging countries. Also, favorable reimbursement programs and encouraging incentives and investments by the developed countries in the region boost the market growth.
The German catheters market reported USD 0.26 billion in revenue in 2018, and it is predicted to dominate the European catheters market in the coming years. The rising geriatric population suffering from urinary incontinence and the number of surgeries is expected to fuel the country's market growth. Over the years, there were 410,557 and 128,004 Gynecology and urology surgeries performed in Germany. However, the increasing number of surgeries performed and the extending of hospital stays are factors expected to drive the urinary catheters market in Germany during the projected period 2020-2026.
Over the forecast period, Italy catheter market is expected to be the second-largest country in accounting European catheter market share. The factors such as the increasing awareness of urinary catheters for the treatment of urinary incontinence and availability of advanced catheter in the country is likely to develop the market growth. However, due to the number of surgeries in the region, the market is expected to grow faster from 2021 to 2026.
KEY MARKET PLAYERS:
Companies dominating the European catheters market profiled in this report are Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company, Abbott, B. Braun Melsungen AG, ConvaTec Group PLC, Coloplast Group, Cook Medical, Edwards Lifesciences Corporation, Johnson & Johnson Services, Merit Medical Systems, Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Hollister Incorporated, AMG International GmbH, Simeks Tibbi Ürünler, Alvimedica, Medinol Ltd and Amsino International, Inc.